SHIRONDA BLAKE: Open Payments
NPI 1306510805 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,757 in 68 payments from 8 companies in 2025. Trend: 2023 $1,199 · 2024 $1,368 · 2025 $1,757
Food & beverage: $1,663Education: $93
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $506 |
| Janssen Biotech, Inc. | 16 | $461 |
| Ardelyx, Inc. | 16 | $320 |
| Gilead Sciences, Inc. | 5 | $230 |
| Phathom Pharmaceuticals, Inc. | 2 | $152 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $48 |
| GENZYME CORPORATION | 1 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $9 |
Products named: TREMFYA, IBSRELA, RINVOQ, SKYRIZI, VOQUEZNA, LINZESS, ENTYVIO, DUPIXENT.
Industry payments across LA — which companies pay providers there.
